Axiom Biosciences
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3280 Grey Hawk Ct, Carlsbad, California,...Website
www.axiombio.coRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Axiom Biosciences
Axiom Biosciences (formerly Cytonus Therapeutics) is a clinical-stage biotechnology company developing next-generation regenerative therapies and targeted biologics. Through advanced cellular engineering and translational science, the company is building a pipeline of therapies designed to address some of the most challenging diseases across neurology, inflammation, and regenerative medicine.Explore more
Axiom Biosciences Org Chart
RK
Research Associate II
JL
Research Associate II
MK
Research Scientist
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Axiom Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Axiom Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Axiom Biosciences had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Axiom Biosciences has new funding data
Product Launch: Get notified when Axiom Biosciences launches new products
Check out if Axiom Biosciences is spiking on competitors!
Earning: See what the market has to say on Axiom Biosciences recently announced quarterly report
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Axiom Biosciences
Check if Axiom Biosciences has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Axiom Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Axiom Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Axiom Biosciences.
Axiom Biosciences News & Media
Axiom Biosciences Announces Intention to Become the First U.S. Biotech to List on the Hong Kong Stock Exchange
SAN DIEGO, July 21, 2026 (GLOBE NEWSWIRE) -- Axiom Biosciences, a clinical-stage biotechnology company whose lead regenerative therapy produced positive early results in newborns with severe brain injury, today announced its intention to pursue an initial public offering on the Main Board of The Stock Exchange of Hong Kong (HKEX). The company believes the proposed listing would position it as the first U.S. biotechnology company to pursue a primary listing in Hong Kong, reflecting aAxiom Biosciences Reports Positive Phase 1 Results for Investigational Stem Cell Therapy in Newborns with Severe Brain Injury
SAN DIEGO, July 14, 2026 (GLOBE NEWSWIRE) -- Axiom Biosciences, a clinical-stage biotechnology company developing next-generation regenerative therapies and targeted biologics, today announced positive Phase 1 results for its investigational Wharton’s Jelly-derived mesenchymal stem cell (WJ-MSC) therapy for neonatal brain injury. The therapy, co-developed with South Korea-based Medinno Inc., is being developed to treat intraventricular hemorrhage (IVH) and hypoxic-ischemic encephalopathy (HIE),
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Axiom Biosciences
Sign Up For FreeTo access detailed company insights
Axiom Biosciences (formerly Cytonus Therapeutics) is a clinical-stage biotechnology company developing next-generation regenerative therapies and targeted biologics. Through advanced cellular engineering and translational science, the company is building a pipeline of therapies designed to address some of the most challenging diseases across neurol... Read More
